Clinical Trials Directory

Trials / Completed

CompletedNCT02363894

DEFINITIVE AR Two Year Follow-up Extension Study

Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
Medtronic Endovascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this DEFINITIVE AR Two Year Follow-up Extension Study is to gather data to assess and estimate the long term effect of treating a vessel with plaque excision (PE) in combination with paclitaxel-coated balloon angioplasty (PTX PTA) compared to treatment with PTX PTA alone.

Conditions

Timeline

Start date
2015-03-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-02-16
Last updated
2016-02-02

Source: ClinicalTrials.gov record NCT02363894. Inclusion in this directory is not an endorsement.

DEFINITIVE AR Two Year Follow-up Extension Study (NCT02363894) · Clinical Trials Directory